Literature DB >> 25893985

Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine.

Yin-Xu Zhang1, Xiao-Mei Liu, Jing Wang, Jun Li, Ying Liu, Hua Zhang, Xue-Wen Yu, Ning Wei.   

Abstract

PUMA (p53 unregulated modulator of apoptosis), a BH3-only Bcl-2 family member, can be induced by p53-dependent and p53-independent manners. It plays an important role as regulator of cellular apoptosis. Herein, we evaluate the effects of H1 (a derivative of tetrandrine) on induction of PUMA and underlie its potential mechanism in p53-independent cytotoxic response. Anti-proliferative activity and evidently cytotoxic activity of H1 were observed in wild-type and p53 null cells. Further studies demonstrated that H1 resulted in an increase of cleaved PARP, decease of survivin and elevation of p-H2AX. What is more, H1 significantly induced PUMA expression in a concentration- and time-dependent manner and caused an increase of Bax/Bcl-2 ratio in p53 null cells. Of note, knockdown of PUMA attenuated cytotoxic activity of H1. Further studies demonstrated that inhibition of AKT/FoxO3a signaling contributed to H1-mediated PUMA induction. Targeted suppression of AKT/FoxO3a signaling by siRNA could overcome H1-mediated PUMA induction. In addition, H1 significantly suppressed NF-κB activity and caused an increase of early apoptotic and late apoptotic cells, and elevated caspase-3 activity. Taken together, we found that inhibition of AKT/FoxO3a signaling may contribute to H1-mediated PUMA induction, suggesting that inhibition of AKT/FoxO3a signaling result in PUMA expression in response to p53-independent cytotoxic effects of H1.

Entities:  

Keywords:  AKT/FoxO3a signaling; FoxO3a, Forkhead Homeobox type O3a; NF-κB, Nuclear Factor Kappa-light-chain-enhancer of activated B cells; PARP, Poly ADP (Adenosine Diphosphate)-Ribose Polymerase; PUMA, p53 Unregulated Modulator of Apoptosis; Tet, Tetrandrine; TNF-α, Tumor Necrosis Fa; PUMA; apoptosis; cytotoxicity; p53; tetrandrine

Mesh:

Substances:

Year:  2015        PMID: 25893985      PMCID: PMC4622009          DOI: 10.1080/15384047.2015.1040950

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  34 in total

1.  PUMA induces the rapid apoptosis of colorectal cancer cells.

Authors:  J Yu; L Zhang; P M Hwang; K W Kinzler; B Vogelstein
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

2.  PUMA, a novel proapoptotic gene, is induced by p53.

Authors:  K Nakano; K H Vousden
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

3.  PUMA induction by FoxO3a mediates the anticancer activities of the broad-range kinase inhibitor UCN-01.

Authors:  Crissy Dudgeon; Peng Wang; Xiameng Sun; Rui Peng; Quanhong Sun; Jian Yu; Lin Zhang
Journal:  Mol Cancer Ther       Date:  2010-10-26       Impact factor: 6.261

4.  H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2.

Authors:  Ning Wei; Geng-Tao Liu; Xiao-Guang Chen; Qian Liu; Feng-Peng Wang; Hua Sun
Journal:  Biochem Pharmacol       Date:  2011-08-17       Impact factor: 5.858

5.  Direct interaction of Bax and Bak proteins with Bcl-2 homology domain 3 (BH3)-only proteins in living cells revealed by fluorescence complementation.

Authors:  Laura Vela; Oscar Gonzalo; Javier Naval; Isabel Marzo
Journal:  J Biol Chem       Date:  2013-01-02       Impact factor: 5.157

6.  JNK- and Akt-mediated Puma expression in the apoptosis of cisplatin-resistant ovarian cancer cells.

Authors:  Zhiwei Zhao; Jingjing Wang; Jingsheng Tang; Xinyu Liu; Qian Zhong; Fang Wang; Wenbin Hu; Zhu Yuan; Chunlai Nie; Yuquan Wei
Journal:  Biochem J       Date:  2012-06-01       Impact factor: 3.857

7.  The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.

Authors:  L W Fu; Y M Zhang; Y J Liang; X P Yang; Q C Pan
Journal:  Eur J Cancer       Date:  2002-02       Impact factor: 9.162

8.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

Review 9.  Activation and activities of the p53 tumour suppressor protein.

Authors:  E Bálint E; K H Vousden
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

10.  The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells.

Authors:  Ning Wei; Edward Chu; Shao-yu Wu; Peter Wipf; John C Schmitz
Journal:  Oncotarget       Date:  2015-03-10
View more
  11 in total

1.  Inhibition on Proteasome β1 Subunit Might Contribute to the Anti-Cancer Effects of Fangchinoline in Human Prostate Cancer Cells.

Authors:  Dong Li; Yu Lu; Peng Sun; Li-Xing Feng; Miao Liu; Li-Hong Hu; Wan-Ying Wu; Bao-Hong Jiang; Min Yang; Xiao-Bo Qu; De-An Guo; Xuan Liu
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

2.  Idelalisib induces PUMA-dependent apoptosis in colon cancer cells.

Authors:  Shida Yang; Zhiyong Zhu; Xiaobing Zhang; Ning Zhang; Zhicheng Yao
Journal:  Oncotarget       Date:  2017-01-24

3.  Mitoxantrone induces apoptosis in osteosarcoma cells through regulation of the Akt/FOXO3 pathway.

Authors:  See-Hyoung Park; Jongsung Lee; Mi-Ae Kang; Kyu Yun Jang; Jung Ryul Kim
Journal:  Oncol Lett       Date:  2018-04-20       Impact factor: 2.967

4.  Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.

Authors:  Fanni Li; Xiwen Dong; Peng Lin; Jianli Jiang
Journal:  Int J Mol Sci       Date:  2018-01-23       Impact factor: 5.923

5.  DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer.

Authors:  Yajie Wang; Hua Sun; Zhiyan Xiao; Gang Zhang; Dan Zhang; Xiuqi Bao; Fangfang Li; Shaoyu Wu; Yuanchao Gao; Ning Wei
Journal:  Cell Commun Signal       Date:  2018-09-03       Impact factor: 5.712

6.  Purified vitexin compound 1, a new neolignan isolated compound, promotes PUMA-dependent apoptosis in colorectal cancer.

Authors:  Jingfei Chen; Juchang Zhong; Yeying Liu; Yuan Huang; Fei Luo; Yingjun Zhou; Xi Pan; Shousong Cao; Lingling Zhang; Yingjie Zhang; Jiangang Wang
Journal:  Cancer Med       Date:  2018-11-06       Impact factor: 4.452

7.  Silencing of lncRNA AFAP1-AS1 Inhibits Cell Growth and Metastasis in Clear Cell Renal Cell Carcinoma.

Authors:  Zhongyi Mu; Dan Dong; Ning Wei; Mingli Sun; Wei Wang; Yue Shao; Jian Gao; Ping Yin; Chenghai Zhao
Journal:  Oncol Res       Date:  2019-03-04       Impact factor: 5.574

8.  Hepatitis B Virus-Like Particle: Targeted Delivery of Plasmid Expressing Short Hairpin RNA for Silencing the Bcl-2 Gene in Cervical Cancer Cells.

Authors:  Made Angga Akwiditya; Chean Yeah Yong; Mohd Termizi Yusof; Abdul Razak Mariatulqabtiah; Kok Lian Ho; Wen Siang Tan
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

Review 9.  Exploring the recent trends in perturbing the cellular signaling pathways in cancer by natural products.

Authors:  Md Mominur Rahman; Md Taslim Sarker; Mst Afroza Alam Tumpa; Md Yamin; Tamanna Islam; Moon Nyeo Park; Md Rezaul Islam; Abdur Rauf; Rohit Sharma; Simona Cavalu; Bonglee Kim
Journal:  Front Pharmacol       Date:  2022-09-08       Impact factor: 5.988

10.  XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma.

Authors:  Yajie Wang; Hua Sun; Zhiyan Xiao; Dan Zhang; Xiuqi Bao; Ning Wei
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.